Acro Biomedical (ACBM) Cash from Operations Growth (1y) (2016 - 2025)
Powered by 
Analysis
Acro Biomedical (ACBM) Cash from Operations Growth (1y) (2016 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Colgate Palmolive | 70.27 Bn | 68.90 Bn | 3.30 Bn | 12.56% |
| 2 | Kenvue | 34.17 Bn | 33.06 Bn | 2.30 Bn | 10.79% |
| 3 | Kimberly Clark | 32.86 Bn | 31.91 Bn | 1.60 Bn | 17.92% |
| 4 | Bath & Body Works | 3.85 Bn | 3.05 Bn | 692.00 Mn | - |
| 5 | Prestige Consumer Healthcare | 2.32 Bn | 2.26 Bn | - | - |
| 6 | Perrigo | 1.99 Bn | 1.59 Bn | 313.90 Mn | 8.83% |
| 7 | Herbalife | 1.32 Bn | 946.20 Mn | 1.03 Bn | -65.73% |
| 8 | Edgewell Personal Care | 1.24 Bn | 842.99 Mn | 242.50 Mn | 3.40% |
| 9 | TFA Therapeutics | 1.02 Bn | 1.02 Bn | - | - |
| 10 | Acro Biomedical | 1.80 Mn | 1.80 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -141.34% |
| Sep 30, 2025 | -758.88% |
| Jun 30, 2025 | -1,384.97% |
| Mar 31, 2025 | -66.74% |
| Dec 31, 2024 | 16.63% |
| Sep 30, 2024 | -1,411.59% |
| Jun 30, 2024 | -381.29% |
| Mar 31, 2024 | -142.78% |
| Dec 31, 2023 | -19.35% |
| Sep 30, 2023 | 100.91% |
| Jun 30, 2023 | 100.65% |
| Mar 31, 2023 | -102.12% |
| Dec 31, 2022 | 82.53% |
| Sep 30, 2022 | 17.48% |
| Jun 30, 2022 | -179.90% |
| Mar 31, 2022 | 3,228.07% |
| Sep 30, 2021 | 0.08% |
| Jun 30, 2021 | 702.48% |
| Mar 31, 2021 | 67.79% |
| Sep 30, 2020 | 31.74% |